V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310008893 | 310003500 | 1.61 | null | Palliative (P) | 2013-11-12 | 2013-11-27 | Trial Unspecified | 02 | N | 310006486 | TRIAL |
| 310008895 | 310003503 | 1.53 | 110 | Palliative (P) | 2019-06-22 | 2019-07-06 | Liposomal Doxorubicin 40mg/m2 | N | N | 310006501 | LIPOSOMAL DOXORUBICIN |
| 310008896 | 310011489 | 1.56 | 53.5 | Curative (C) | 2014-09-28 | 2014-11-13 | CHOP | N | N | 310006516 | CHOP |
| 310008897 | 310003506 | 1.72 | 65 | Palliative (P) | 2014-08-18 | 2015-04-28 | Bevacizumab | N | N | 310006525 | BEVACIZUMAB |
| 310008898 | 310003508 | 1.72 | 85 | Not known (9) | 2018-04-18 | 2018-04-19 | Bevacizumab 7.5mg/kg | 02 | N | 310006540 | BEVACIZUMAB |
| 310008899 | 310003510 | 1.67 | 54.9 | Curative (C) | 2018-09-17 | 2018-09-18 | CHOP - 21 days | N | N | 310006559 | CHOP |
| 310008900 | 310003512 | 1.61 | 125.85 | Disease modification (D) | 2017-07-25 | 2017-07-26 | Trial Unspecified | 01 | N | 310006571 | TRIAL |
| 310008901 | 310003513 | 1.65 | 77.9 | Palliative (P) | 2014-03-02 | 2014-03-14 | GemCarbo Days 1+8 | null | N | 310006572 | GEMCARBO |
| 310008902 | 310007418 | 1.84 | 101 | Palliative (P) | 2017-06-01 | 2017-06-11 | Bevacizumab 7.5mg/kg | N | N | 310006575 | BEVACIZUMAB |
| 310008903 | 310003517 | null | 96.8 | Palliative (P) | 2014-06-25 | 2014-06-26 | Bevacizumab 15mg/kg | N | N | 310006576 | BEVACIZUMAB |
| 310008904 | 310003522 | 1.74 | 77.8 | null | 2015-09-05 | 2015-09-06 | Bevacizumab | 2 | N | 310006577 | BEVACIZUMAB |
| 310008905 | 310007422 | 1.62 | 78.3 | Disease modification (D) | 2014-10-03 | 2015-07-08 | LIPOSOMAL DOXORUBICIN | 02 | N | 310006596 | LIPOSOMAL DOXORUBICIN |
| 310008906 | 310007422 | 1.86 | 69.1 | Palliative (P) | 2017-03-05 | 2017-03-05 | CARBOPLATIN + GEMCITABINE | 2 | N | 310006596 | GEMCARBO |
| 310008907 | 310011689 | 1.62 | 73 | Palliative (P) | 2017-07-12 | 2017-07-14 | Liposomal Doxorubicin 50mg/m2 | N | N | 310006612 | LIPOSOMAL DOXORUBICIN |
| 310008908 | 310003526 | 1.46 | 67.8 | Palliative (P) | 2017-12-02 | 2017-12-10 | CARBOPLATIN + GEMCITABINE | N | N | 310006620 | GEMCARBO |
| 310008909 | 310003528 | 1.76 | 78.5 | Palliative (P) | 2017-07-16 | 2017-07-18 | CHOP - 21 days | null | N | 310006623 | CHOP |
| 310008910 | 310003534 | 1.7 | 66 | Palliative (P) | null | 2017-03-21 | CARBOPLATIN + GEMCITABINE | N | null | 310006631 | GEMCARBO |
| 310008911 | 310003536 | 0 | 71.5 | Palliative (P) | 2013-10-09 | 2015-04-26 | Bevacizumab 7.5mg/kg | 02 | N | 310006637 | BEVACIZUMAB |
| 310008912 | 310003538 | 1.66 | 69.8 | Palliative (P) | 2016-09-30 | 2016-09-30 | Bevacizumab 7.5mg/kg | 02 | N | 310006643 | BEVACIZUMAB |
| 310008913 | 310003541 | 1.55 | 76 | Palliative (P) | 2015-08-09 | 2015-08-23 | Bevacizumab 7.5mg/kg | N | null | 310006647 | BEVACIZUMAB |
| 310008914 | 310003542 | 1.63 | null | Palliative (P) | 2016-03-30 | 2016-04-04 | CHOP - 21 days | null | N | 310006664 | CHOP |
| 310008915 | 310007430 | 1.52 | 74.6 | Palliative (P) | 2018-11-27 | 2018-12-03 | Bevacizumab 7.5mg/kg | 02 | N | 310006675 | BEVACIZUMAB |
| 310008916 | 310007431 | 1.69 | 100 | null | 2015-05-11 | 2015-05-27 | CHOP - 14 days | N | N | 310006679 | CHOP |
| 310008917 | 310003548 | 1.67 | 94.1 | Palliative (P) | 2016-05-07 | 2016-05-07 | Liposomal Doxorubicin (Caelyx) | N | N | 310006681 | LIPOSOMAL DOXORUBICIN |
| 310008918 | 310003550 | 1.51 | 83 | Palliative (P) | 2015-12-19 | 2016-01-05 | CHOP - 21 days | 02 | N | 310006686 | CHOP |
| 310008919 | 310003552 | 1.65 | null | Palliative (P) | 2016-04-30 | 2016-06-04 | Trial Unspecified | Y | N | 310006695 | TRIAL |
| 310008920 | 310003554 | null | 129 | Palliative (P) | 2014-08-26 | 2014-10-01 | Liposomal Doxorubicin 40mg/m2 | N | N | 310006718 | LIPOSOMAL DOXORUBICIN |
| 310008921 | 310003556 | 1.84 | 69.3 | Palliative (P) | 2014-05-31 | 2015-07-21 | Liposomal Doxorubicin 50mg/m2 | 02 | N | 310006724 | LIPOSOMAL DOXORUBICIN |
| 310008922 | 310003558 | 1.61 | 81.6 | Palliative (P) | 2014-06-07 | 2014-06-20 | Liposomal Doxorubicin (Caelyx) | N | N | 310006726 | LIPOSOMAL DOXORUBICIN |
| 310008923 | 310003563 | null | 66.3 | Disease modification (D) | 2014-09-05 | 2014-09-05 | Selumetinib | Y | N | 310006737 | TRIAL |
| 310008924 | 310003564 | 1.57 | 82.3 | Palliative (P) | 2017-06-01 | 2017-06-15 | CHOP | 99 | N | 310006742 | CHOP |
| 310008925 | 310003567 | 1.58 | 89.6 | Palliative (P) | 2015-10-16 | 2015-10-16 | Trial Unspecified | N | N | 310006747 | TRIAL |
| 310008926 | 310003570 | 1.59 | 59.6 | Palliative (P) | 2014-11-10 | 2014-11-11 | CHOP - 14 days | 02 | N | 310006751 | CHOP |
| 310008927 | 310003573 | 1.76 | null | Neo-adjuvant (N) | 2017-03-25 | 2017-10-04 | Liposomal Doxorubicin 50mg/m2 | 02 | N | 310006760 | LIPOSOMAL DOXORUBICIN |
| 310008928 | 310009466 | 1.78 | 54.2 | Palliative (P) | 2017-04-30 | 2017-05-22 | Liposomal Doxorubicin 40mg/m2 | N | N | 310006763 | LIPOSOMAL DOXORUBICIN |
| 310008929 | 310003578 | 1.63 | 72.9 | Palliative (P) | 2017-03-03 | 2017-03-04 | GemCarbo Days 1+8 | 02 | N | 310006764 | GEMCARBO |
| 310008931 | 310009467 | 1.6 | 79.6 | Palliative (P) | 2015-05-30 | 2015-06-03 | Trial Unspecified | Y | N | 310006772 | TRIAL |
| 310008932 | 310009467 | 1.72 | 82.2 | Palliative (P) | null | 2013-04-15 | CHOP - 21 days | 02 | N | 310006772 | CHOP |
| 310008933 | 310003584 | 1.59 | 77 | Palliative (P) | 2014-02-21 | 2015-04-04 | Bevacizumab 15mg/kg | 2 | N | 310006785 | BEVACIZUMAB |
| 310008934 | 310003591 | null | 91.55 | Palliative (P) | 2017-07-20 | 2017-07-20 | CHOP - 21 days | N | null | 310006795 | CHOP |
| 310008935 | 310003593 | 1.78 | 86.4 | Disease modification (D) | 2016-07-02 | 2016-07-29 | Bevacizumab 7.5mg/kg | N | N | 310006818 | BEVACIZUMAB |
| 310008936 | 310003594 | null | 67.6 | Palliative (P) | 2014-11-02 | 2015-05-25 | Bevacizumab 15mg/kg | N | N | 310006819 | BEVACIZUMAB |
| 310008937 | 310003595 | 1.73 | null | Palliative (P) | 2016-03-30 | 2016-03-30 | Liposomal Doxorubicin (Caelyx) | 02 | N | 310006823 | LIPOSOMAL DOXORUBICIN |
| 310008938 | 310003596 | null | 100 | Curative (C) | 2016-06-06 | 2016-11-03 | CHOP | N | N | 310006828 | CHOP |
| 310008939 | 310007449 | 1.75 | 69.7 | Not known (9) | 2013-10-07 | 2013-10-21 | Bevacizumab 7.5mg/kg | 02 | N | 310006829 | BEVACIZUMAB |
| 310008940 | 310003600 | 1.55 | 59 | Palliative (P) | 2019-02-14 | 2019-02-16 | GemCarbo Days 1+8 | N | N | 310006847 | GEMCARBO |
| 310008941 | 310003600 | 1.65 | null | Curative (C) | 2014-02-22 | 2014-06-14 | CHOP - 21 days | 2 | N | 310006847 | CHOP |
| 310008942 | 310003602 | 1.57 | 73 | Palliative (P) | 2014-06-25 | 2014-07-14 | Liposomal Doxorubicin 40mg/m2 | N | N | 310006858 | LIPOSOMAL DOXORUBICIN |
| 310008943 | 310003604 | 1.64 | 63.3 | Palliative (P) | 2017-12-24 | 2017-12-31 | CHEMO-T TRIAL | 01 | N | 310006869 | TRIAL |
| 310008944 | 310003606 | 1.78 | 101 | Palliative (P) | null | 2016-01-16 | CHOP - 21 days | 02 | N | 310006872 | CHOP |